🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Neuromuscular; Disorder, Hereditary

Longitudinal Quantitative Neuromuscular MRI in Neuropathic Patients NCT06845644NA1 site📍 Marseille Assistance Publique Hopitaux De Marseille · Tests: Quantitative neuromuscular MRI, Neuromuscular ultrasound Echocardiographic Characterization of Cardiac Amyloidosis NCT05760287n/a1 site📍 Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS Concordance for Transthyretin Amyloidosis Between Synovial Biopsy and Anterior Carpal Ligament Biopsy NCT07644325NA1 site📍 Montpellier Clinique Saint Jean, France · Tests: Annular ligament biopsy BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases NCT06794008Phase 21 site📍 Beijing Peking University People's Hospital · Tests: BCMA-CD19 CAR-T therapy Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health Patients With Congenital Myasthenic Syndrome Will be Treated With Umbilical or Placental Derived Mesenchymal Stem Cell Exosome Solution NCT07226726Phase 12 sites📍 Naples📍 Athens The Foundation for Orthopaedics and Regenerative Medicine · Tests: AlloEx exosomes HL-085 in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas NCT05331105Phase 21 site📍 Shanghai Shanghai Kechow Pharma, Inc. · Tests: HL-085 Clinical Trial Readiness for the Dystroglycanopathies NCT00313677n/a1 site📍 Iowa City Katherine Mathews A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1) NCT07723248Phase 312 sites📍 Coral Springs📍 Jeffersonville📍 Holland ORIC Pharmaceuticals · Tests: Rinzimetostat, Darolutamide, Enzalutamide, Docetaxel Muscle Health Measurements Using Electrical Impedance Myography NCT07502989n/a1 site📍 Boston Beth Israel Deaconess Medical Center · Tests: Electrical Impedance Myography Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study NCT03373968Phase 2, Phase 339 sites📍 Sacramento📍 San Diego📍 Hartford Italfarmaco · Tests: Givinostat The United Kingdom Facioscapulohumeral Muscular Dystrophy Patient Registry NCT04001582n/a1 site📍 Newcastle upon Tyne Newcastle University · Tests: Patient Registry Precision TOF-Guided Sugammadex Versus Spontaneous Recovery for Early Extubation in Minimally Invasive Pediatric Cardiac Surgery NCT07798011n/a1 site📍 Hanoi Dr. Nguyen Thi Thu Hang · Tests: Sugammadex A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy NCT07047144Phase 223 sites📍 Phoenix📍 Orange📍 Palo Alto Scholar Rock, Inc. · Tests: Apitegromab, Nusinersen, Risdiplam KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases NCT06451757Phase 310 sites📍 Boston📍 Cleveland📍 Houston Khondrion BV · Tests: Sonlicromanol, Placebo WiTNNess - TNNT1 Myopathy Natural History Study NCT06374719n/a1 site📍 Gordonville Clinic for Special Children A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers) NCT07064122Phase 121 sites📍 Miami📍 Tampa📍 Houston AstraZeneca · Tests: AZD2962 Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas NCT05253131Phase 21 site📍 Birmingham University of Alabama at Birmingham · Tests: Selumetinib + ZEN-3694 ± Durvalumab Carboplatin or Olaparib for BRcA Deficient Prostate Cancer NCT04038502Phase 218 sites📍 West Los Angeles📍 Aurora📍 Washington D.C. VA Office of Research and Development · Tests: Carboplatin, Olaparib Cardiac Amyloid Deposits and Heart Dysfunction in Alzheimer's Disease NCT07154394n/a1 site📍 Essen University Hospital, Essen Respiratory Muscles and Work of Breathing in Children NCT05051254NA1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Esogastric pressure measurement Retinal Imaging in Neurodegenerative Disease NCT03233646n/a1 site📍 Durham Duke University · Tests: Retinal and Choroidal Imaging A Remote Study Using Technology to Assess Outcomes in DMD NCT07423026n/a1 site📍 Oxford University of Oxford Biomarker Development for Muscular Dystrophies NCT05019625n/a5 sites📍 Boston📍 Boston📍 Boston Massachusetts General Hospital Real-World Effects of MC4R Agonist Therapy in BBS and Severe Genetic Obesity NCT07674290Phase 41 site📍 Essen Tom Hühne · Tests: Setmelanotide AUTONOMOUS DISORDERS IN CMT NCT07570446n/a1 site📍 Göttingen University Medical Center Goettingen Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1 NCT07102394Phase 11 site📍 Baltimore Johns Hopkins University · Tests: Imlygic An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE) NCT07220603Phase 23 sites📍 Calgary📍 Ottawa📍 Saguenay PepGen Inc · Tests: PGN-EDODM1 Study of ACR-2316 in Specific Advanced Solid Tumors NCT06667141Phase 1, Phase 215 sites📍 Phoenix📍 Beverly Hills📍 Newport Beach Acrivon Therapeutics · Tests: ACR-2316 A Prospective Cohort Study of Surgical Treatment for Foot Deformities in HSP NCT06936163n/a1 site📍 Shanghai Shanghai 6th People's Hospital
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy